Close Menu
Influential MagazineInfluential Magazine
  • Home
  • Latest News
  • Entrepreneurs
  • Business
  • Finance
  • Leadership
  • More
    • Web Stories
    • Editor’s Picks
    • Press Release

Subscribe to Updates

Get the latest business and finance news for entrepreneurs all around the world.

What's Hot
Do You Know the Jobs These Authors Had Before They Found Literary Success?

Do You Know the Jobs These Authors Had Before They Found Literary Success?

June 2, 2025
The Imports the U.S. Relies On Most From 140 Nations, From Albania to Zimbabwe

The Imports the U.S. Relies On Most From 140 Nations, From Albania to Zimbabwe

June 2, 2025
Video: Toy Company Still In Crisis Despite Reduced Tariffs on China

Video: Toy Company Still In Crisis Despite Reduced Tariffs on China

May 27, 2025
Facebook X (Twitter) Instagram
Facebook X (Twitter) Instagram
Influential MagazineInfluential Magazine
SUBSCRIBE
  • Home
  • Latest News
  • Entrepreneurs
  • Business
  • Finance
  • Leadership
  • More
    • Web Stories
    • Editor’s Picks
    • Press Release
Influential MagazineInfluential Magazine
Home » Isomorphic Labs, Google’s A.I. Drug Business, Raises Money From Thrive

Isomorphic Labs, Google’s A.I. Drug Business, Raises Money From Thrive

March 31, 20254 Mins Read Business
Isomorphic Labs, Google’s A.I. Drug Business, Raises Money From Thrive
Share
Facebook Twitter Reddit Telegram Pinterest Email

Over the last 12 months, Google’s efforts to use artificial intelligence to accelerate drug design have achieved breakthroughs in mimicking human biology and won its top scientists the Nobel Prize in Chemistry.

Now Isomorphic Labs, the division within the software giant meant to develop and commercialize the technology, is taking another big step: raising money from an outside investor.

Isomorphic plans to announce on Monday that it has raised $600 million, led by Thrive Capital, the venture capital firm that has bet big on A.I. companies including OpenAI. GV, Google’s venture capital arm, and Alphabet, Google’s parent company, also invested.

The announcement underscores Google’s ambitions for Isomorphic, which was spun out of the company’s DeepMind lab to focus on drugs discovery. It is built on software that DeepMind, a central intelligence lab in London, has developed. That includes AlphaFold, which can predict the structure of millions of proteins and more.

AlphaFold, which now in its third iteration can predict the complex behavior of DNA and RNA, has promised to slash the development time of new drugs. Such is its promise that Demis Hassabis, a co-founder of Isomorphic and DeepMind, and John M. Jumper, a DeepMind researcher, shared half of the Nobel in chemistry last year.

The goal, according to Mr. Hassabis, is to eventually conduct most of the drug discovery process via computers, rather than traditional labs that require biological materials, strict safety requirements — and lots of time.

“This is the No. 1 most beneficial application of A.I. out there,” Mr. Hassabis said in an interview. He added, “Our mission, one day, is to solve all disease” with A.I.

Isomorphic is researching potential treatments, including those focused on cancer and immune disorders. Last year, it signed research partnerships with two major drug makers, Eli Lilly and Novartis, that could yield billions in payouts via promising drugs breakthroughs.

But as with many things related to A.I., the work, and the hiring of top research talent to perform it, is expensive. Mr. Hassabis said that Isomorphic didn’t need capital — its parent company reported more than $100 billion in profit last year — but it made sense to bring in an outside partner.

By Mr. Hassabis’s thinking, doing so had long been a possibility. But he added that he had wanted a backer fixed on the long term that was also deeply focused on life sciences.

The additional money will help Isomorphic expand its stable of research models like Alphafold, as well as recruit top talent across scientific disciplines.

“The ambition of the company is to be a full stack life science company, so that requires more capital to create more drugs while also investing in the technology platform,” said Vince Hankes, a Thrive partner who has led many of the firm’s A.I. investments.

Mr. Hassabis added that he wanted to be selective in Isomorphic’s partners; formal talks with Thrive took place over a matter of months.

The fund-raising is another major bet by the 15-year-old Thrive, which has minted money investing in companies like Instagram and the payments processor Stripe. Of late, it has centered on A.I. companies, including leading a recent round in OpenAI that nearly doubled its valuation to $157 billion, as well as the analytics provider Databricks and the programming start-up Anysphere.

“Our hope is that A.I. radically changes the way drugs are created and discovered,” said Joshua Kushner, Thrive’s founder and managing partner. “Isomorphic is pushing the boundaries of what is possible in small-molecule drug discovery.”

Over the next year or so, Isomorphic hopes to have made more breakthroughs in computational models like Alphafold and perhaps have drug candidates get close to preclinical trials, Mr. Hassabis said.

Isomorphic will probably raise money from more outside investors, he added. The goal is for the company to be an independent business.

“This will be one of the most consequential companies around,” he said. “We want it to be a real powerhouse in the industry.”

Alphabet Inc Artificial Intelligence Demis Drugs (Pharmaceuticals) Hassabis Isomorphic Labs Ltd Joshua Kushner Start-ups Thrive Capital
Share. Facebook Twitter Pinterest LinkedIn Telegram Reddit Email
Previous ArticlePrimark CEO Resigns After ‘Error of Judgment’
Next Article Can the Army Make Food Its Soldiers Want to Eat?

Related Posts

Do You Know the Jobs These Authors Had Before They Found Literary Success?

Do You Know the Jobs These Authors Had Before They Found Literary Success?

June 2, 2025
The Imports the U.S. Relies On Most From 140 Nations, From Albania to Zimbabwe

The Imports the U.S. Relies On Most From 140 Nations, From Albania to Zimbabwe

June 2, 2025
Video: Toy Company Still In Crisis Despite Reduced Tariffs on China

Video: Toy Company Still In Crisis Despite Reduced Tariffs on China

May 27, 2025
Plastic Spoons, Umbrellas, Violins: A Guide to What Americans Buy From China

Plastic Spoons, Umbrellas, Violins: A Guide to What Americans Buy From China

May 24, 2025
Are You Smarter Than a Billionaire?

Are You Smarter Than a Billionaire?

May 22, 2025
Markets Head Lower in Wake of Concerns About U.S. Debt

Markets Head Lower in Wake of Concerns About U.S. Debt

May 19, 2025
Add A Comment

Leave A Reply Cancel Reply

Demo
Stay In Touch
  • Facebook
  • Twitter
  • Pinterest
  • Instagram
  • YouTube
  • Vimeo
Don't Miss
Do You Know the Jobs These Authors Had Before They Found Literary Success?

Do You Know the Jobs These Authors Had Before They Found Literary Success?

By News RoomJune 2, 2025

Welcome to Lit Trivia, the Book Review’s regular quiz about literary culture. This week’s installment…

The Imports the U.S. Relies On Most From 140 Nations, From Albania to Zimbabwe

The Imports the U.S. Relies On Most From 140 Nations, From Albania to Zimbabwe

June 2, 2025
Video: Toy Company Still In Crisis Despite Reduced Tariffs on China

Video: Toy Company Still In Crisis Despite Reduced Tariffs on China

May 27, 2025
Plastic Spoons, Umbrellas, Violins: A Guide to What Americans Buy From China

Plastic Spoons, Umbrellas, Violins: A Guide to What Americans Buy From China

May 24, 2025

Subscribe to Updates

Get the latest business and finance news for entrepreneurs all around the world.

About Us
About Us

Influential Magazine is one of the top news portals about Business and Finance news for Entrepreneurs and leaders all around the world, follow us for more intersting articles and news.

Our Picks
Plastic Spoons, Umbrellas, Violins: A Guide to What Americans Buy From China

Plastic Spoons, Umbrellas, Violins: A Guide to What Americans Buy From China

May 24, 2025
Are You Smarter Than a Billionaire?

Are You Smarter Than a Billionaire?

May 22, 2025
Wedding Belles Love Expands with Size-Inclusive, Same-Day Bridalwear Boutique

Wedding Belles Love Expands with Size-Inclusive, Same-Day Bridalwear Boutique

May 22, 2025
Trending Now
Father and Son Duo Launch PlayZer Media to Support Southern England’s Grassroots Music Scene

Father and Son Duo Launch PlayZer Media to Support Southern England’s Grassroots Music Scene

May 16, 2025
Beauty Corner in Wellingborough Expands Services with Launch of Dermasculpt Treatment

Beauty Corner in Wellingborough Expands Services with Launch of Dermasculpt Treatment

May 16, 2025
Consumers Show Signs of Strain Amid Trump’s Tariff Rollout

Consumers Show Signs of Strain Amid Trump’s Tariff Rollout

May 15, 2025
Influential Magazine
Facebook X (Twitter) Instagram LinkedIn
  • Home
  • Privacy Policy
  • Contact
  • Terms & Conditions
© 2025 Influential Mag. All Rights Reserved.

Type above and press Enter to search. Press Esc to cancel.